BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 29704918)

  • 1. Microbiota-drug interactions: Impact on metabolism and efficacy of therapeutics.
    Wilkinson EM; Ilhan ZE; Herbst-Kralovetz MM
    Maturitas; 2018 Jun; 112():53-63. PubMed ID: 29704918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of gut microbiota on drug metabolism and toxicity.
    Li H; He J; Jia W
    Expert Opin Drug Metab Toxicol; 2016; 12(1):31-40. PubMed ID: 26569070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Reactions: Breaking Down Xenobiotic-Microbiome Interactions.
    Clarke G; Sandhu KV; Griffin BT; Dinan TG; Cryan JF; Hyland NP
    Pharmacol Rev; 2019 Apr; 71(2):198-224. PubMed ID: 30890566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiome and Response to Cardiovascular Drugs.
    Tuteja S; Ferguson JF
    Circ Genom Precis Med; 2019 Sep; 12(9):421-429. PubMed ID: 31462078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug-microbiome interactions.
    Aziz RK; Hegazy SM; Yasser R; Rizkallah MR; ElRakaiby MT
    Expert Opin Drug Metab Toxicol; 2018 Oct; 14(10):1043-1055. PubMed ID: 30269615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of gut microbiota in the pharmacokinetics of antihypertensive drugs.
    Choi MS; Yu JS; Yoo HH; Kim DH
    Pharmacol Res; 2018 Apr; 130():164-171. PubMed ID: 29391236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting gut microbiota for precision medicine: Focusing on the efficacy and toxicity of drugs.
    Feng W; Liu J; Ao H; Yue S; Peng C
    Theranostics; 2020; 10(24):11278-11301. PubMed ID: 33042283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impacts of the Human Gut Microbiome on Therapeutics.
    Vázquez-Baeza Y; Callewaert C; Debelius J; Hyde E; Marotz C; Morton JT; Swafford A; Vrbanac A; Dorrestein PC; Knight R
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():253-270. PubMed ID: 28968189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omics for Understanding the Gut-Liver-Microbiome Axis and Precision Medicine.
    Khalsa J; Duffy LC; Riscuta G; Starke-Reed P; Hubbard VS
    Clin Pharmacol Drug Dev; 2017 Mar; 6(2):176-185. PubMed ID: 28263462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota modulation of chemotherapy efficacy and toxicity.
    Alexander JL; Wilson ID; Teare J; Marchesi JR; Nicholson JK; Kinross JM
    Nat Rev Gastroenterol Hepatol; 2017 Jun; 14(6):356-365. PubMed ID: 28270698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of gut microbiota on drug metabolism: an update for safe and effective use of drugs.
    Noh K; Kang YR; Nepal MR; Shakya R; Kang MJ; Kang W; Lee S; Jeong HG; Jeong TC
    Arch Pharm Res; 2017 Dec; 40(12):1345-1355. PubMed ID: 29181640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bidirectional interactions between indomethacin and the murine intestinal microbiota.
    Liang X; Bittinger K; Li X; Abernethy DR; Bushman FD; FitzGerald GA
    Elife; 2015 Dec; 4():e08973. PubMed ID: 26701907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The microbiome and cancer for clinicians.
    Picardo SL; Coburn B; Hansen AR
    Crit Rev Oncol Hematol; 2019 Sep; 141():1-12. PubMed ID: 31202124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision Medicine Goes Microscopic: Engineering the Microbiome to Improve Drug Outcomes.
    Lam KN; Alexander M; Turnbaugh PJ
    Cell Host Microbe; 2019 Jul; 26(1):22-34. PubMed ID: 31295421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformation of the Anticancer Drug Doxorubicin in the Human Gut Microbiome.
    Yan A; Culp E; Perry J; Lau JT; MacNeil LT; Surette MG; Wright GD
    ACS Infect Dis; 2018 Jan; 4(1):68-76. PubMed ID: 29160065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota modulates drug pharmacokinetics.
    Zhang J; Zhang J; Wang R
    Drug Metab Rev; 2018 Aug; 50(3):357-368. PubMed ID: 30227749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-gut microbiota interactions: implications for neuropharmacology.
    Walsh J; Griffin BT; Clarke G; Hyland NP
    Br J Pharmacol; 2018 Dec; 175(24):4415-4429. PubMed ID: 29782640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of the Gut Microbiota on Drug Metabolism and Clinical Outcome.
    Enright EF; Gahan CG; Joyce SA; Griffin BT
    Yale J Biol Med; 2016 Sep; 89(3):375-382. PubMed ID: 27698621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between drugs and the gut microbiome.
    Weersma RK; Zhernakova A; Fu J
    Gut; 2020 Aug; 69(8):1510-1519. PubMed ID: 32409589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separating host and microbiome contributions to drug pharmacokinetics and toxicity.
    Zimmermann M; Zimmermann-Kogadeeva M; Wegmann R; Goodman AL
    Science; 2019 Feb; 363(6427):. PubMed ID: 30733391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.